Unicorn Biotechnologies Ltd

Currently, many cellular therapeutics are cultured using labour-intensive, error-prone and costly methods of manufacture. Unicorn Biotechnologies has built an end-to-end fully automated system for the next generation of cell therapy manufacturing that decouples and streamlines human labour involvement. Leading to reduced cost of goods, improved production...

In this project, Future Fields will use cutting-edge genome editing techniques to engineer _Drosophila melanogaster_, where the stable stocks will be induced to express the high-functioning humanised growth factors required for Unicorn Biotechnologies (UB). UB will use these high-functioning proteins within their novel automated and continuous cell passag...

The culture of mammalian cells underpins almost all life science R&D, is involved in the production of many therapeutics including recombinant proteins, antibodies, vaccines and underpins many next-generation therapeutics such as cell therapies for personalised medicine. One significant bottleneck preventing the widespread adoption of such technologies an...

World meat consumption has tripled since 1970 and will increase a further 76% by 2050, posing a significant sustainability challenge. Livestock farming contributes to 15% of human-made greenhouse gas (GHG) emissions, which further exacerbates climate change, environmental destruction, and infectious disease outbreaks. Cultivated meat (CM) is an approach t...

World meat consumption has tripled since 1970 and will increase a further 76% by 2050\. In the future, there will not be enough meat available for the world's population. This shortage will hit low-and-middle-income countries, where meat is an important but limited source of nutrient-dense protein, vitamins and minerals, especially hard. Over 80 billion a...